NASDAQ:YARW | Free Cash Flow | Yarrow Bioscience, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2015-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$4.08M
2025-03-31-$11.46M
2024-12-31-$9M
2024-03-31-$7.98M
2023-12-31-$5.14M
2023-03-31-$5.48M
2022-12-31-$4.81M
2022-03-31-$9.04M
2021-12-31-$10.02M$0.00-$10.02M
2021-03-31-$12.55M$0.00-$12.55M
2020-12-31-$25.38M$0.00-$25.38M
2020-03-31-$52.21M$42,000.00-$52.25M
2019-12-31-$22.25M$197,000.00-$22.44M
2019-03-31-$16.64M$138,000.00-$16.78M
2018-12-31-$32.55M$449,000.00-$33M
2018-03-31-$11.2M
2017-12-31-$10.16M$12,000.00-$10.17M
2017-03-31-$5.58M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$33.12M
2024-12-31-$33.97M
2023-12-31-$25.34M
2022-12-31-$29.2M
2021-12-31-$56.37M$0.00-$56.37M
2020-12-31-$137.08M$113,000.00-$137.2M
2019-12-31-$73.39M$1.06M-$74.45M
2018-12-31-$68.66M$567,000.00-$69.23M
2017-12-31-$28.22M$27,000.00-$28.25M
2016-12-31-$2.27M$31,000.00-$2.3M
2015-12-31-$4.18M$0.00-$4.18M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.